Company profile
Brain Scientific Inc.
OTC: BRSF · Healthcare · Medical - Devices
#997 of 1,418 Healthcare companies by revenue28th-percentile growth
EA Score
——FH —DQ 31GM —SS 19
v0.1 · 25/100 weight · pillars only
↑ growth stability, balance-sheet leverage · ↓ market scale, net margin
Methodology →Revenue TTM
$214.6k
Rev growth YoY (TTM)
-19.3%
Net income (FY)
-$12.3M
Employees
11
as of 2026-08-31
Market cap
$746
as of 2026-08-31
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$214.6k$214.6k2022
Net income-$12.3M-$12.3M2022
Operating income-$9.6M-$9.6M2022
Total assets$11.7M$11.7M2022
Liabilities$7.4M$7.4M2022
Equity$4.3M$4.3M2022
Revenue trend
FY2016 – FY2022 · USD
FY16
FY16
FY18
FY18
FY19
FY20
FY21
FY22
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is Brain Scientific Inc.’s revenue?
Brain Scientific Inc. booked $214.6k in FY2022 revenue, contracting 19% year over year — slower than 72% of Healthcare companies we track, at a -5753.0% net margin.
Peers · Healthcare
Blueberries Medical Corp.32DFamily Office of America Inc.37DHAVN Life Sciences Inc.——Anixa Biosciences, Inc.52DGlucoTrack, Inc.28DSharps Technology, Inc.33DNeighbors
Sarasota →Key facts
CEOHassan Kotob
SectorHealthcare
IndustryMedical - Devices
HeadquartersSarasota, FL
ExchangeOTC: BRSF
Employees11
IPO date2021-01-08
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.